Cargando…
Monomethyl fumarate promotes Nrf2-dependent neuroprotection in retinal ischemia-reperfusion
BACKGROUND: Retinal ischemia results in neuronal degeneration and contributes to the pathogenesis of multiple blinding diseases. Recently, the fumaric acid ester dimethyl fumarate (DMF) has been FDA-approved for the treatment of multiple sclerosis, based on its neuroprotective and anti-inflammatory...
Autores principales: | Cho, Hongkwan, Hartsock, Matthew J., Xu, Zhenhua, He, Meihua, Duh, Elia J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687295/ https://www.ncbi.nlm.nih.gov/pubmed/26689280 http://dx.doi.org/10.1186/s12974-015-0452-z |
Ejemplares similares
-
Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam™ (Monomethyl Fumarate) or Tecfidera(®) (Dimethyl Fumarate)
por: Lategan, Thomas W., et al.
Publicado: (2021) -
Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice
por: Yao, Yang, et al.
Publicado: (2016) -
Structural Study of Monomethyl Fumarate-Bound Human GAPDH
por: Park, Jun Bae, et al.
Publicado: (2019) -
Monomethyl fumarate prevents alloimmune rejection in mouse heart transplantation by inducing tolerogenic dendritic cells: Monomethyl fumarate prevents alloimmune rejection
por: Chen, Juntao, et al.
Publicado: (2023) -
The NRF2 transcriptional target, OSGIN1, contributes to monomethyl fumarate-mediated cytoprotection in human astrocytes
por: Brennan, Melanie S., et al.
Publicado: (2017)